🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ARQ
$ARQT
🔒 US EquitiesArcutis Biotherapeutics, Inc.
AVG HISTORICAL GAP
+5.04%
MAX GAP RECORD
+15.87%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ARQT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ARQT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (16:00)) |
-0.57%
|
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
+7.79%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
-5.59%
|
| Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE) |
+2.52%
|
| Oct 28, 2025 Earnings Release 2025-10-28 (BEFORE OPEN) |
+14.56%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+5.92%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
-0.56%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE) |
+13.52%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.5%
Bullish Gaps (11)
Bearish Gaps (2)
Neutral / Flat (3)
📖 Intelligence Summary
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗